🇺🇸 FDA
Patent

US 12263179

Lyme disease-associated T cell receptor-related methods

granted A61KA61K31/43A61K31/431

Quick answer

US patent 12263179 (Lyme disease-associated T cell receptor-related methods) held by Adaptive Biotechnologies Corporation expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Adaptive Biotechnologies Corporation
Grant date
Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/43, A61K31/431, A61K31/53, A61K31/546